About Marc

Marc is co-head of Cooley’s global life sciences practice and an internationally recognized corporate lawyer with deep experience in the life sciences and biotechnology sectors. He represents a range of public and private companies and investors, advising on all manner of corporate, fundraising and strategic transactions in the US and abroad.

View full bio

Passions

Road cycling

Skiing

Experience

LB Pharmaceuticals Announces $285 Million Upsized IPO

LB Pharmaceuticals Announces $285 Million Upsized IPO

September 12, 2025

Cooley advised LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases including schizophrenia, on its $285 million upsized initial public offering (IPO).

Read more

Related contacts

Brandon W. Fenn
Partner, New York
Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Minkyu Park
Special Counsel, New York
Denny Xu
Associate, Boston
Danbi Kim
Associate, Boston
Ariane A. Andrade
Partner, Chicago
Nathaniel Hearn Jr.
Associate, Chicago
Karun Ahuja
Special Counsel, Chicago
Brandon Lefebvre
Quantitative Analyst, Boston
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
Eileen Marshall
Partner, Washington, DC
Phil Mitchell
Partner, New York
Gerard O'Shea
Partner, New York
David Peinsipp
Partner, San Francisco
Ryan Vann
Partner, Chicago
Francis Wheeler
Senior Counsel, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Jessica Koffel
Special Counsel, Brussels
Rebecca Ross
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Chelsea Braun
Associate, Boston
Cara Buchicchio
Associate, New York
David Dalton
Associate, Santa Monica
Vince Flynn
Associate, San Diego
Virat Gupta
Associate, Washington, DC
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Brenna McGuire
Associate, Washington, DC
Sarah Miller
Associate, New York
Jayne M. Munger
Associate, New York
Miles Patton
Associate, New York
Alla Kagan
Paralegal Specialist, San Diego
Cathy Rude
Paralegal Specialist, Boston
Jake Ironfield
Transactional Quantitative Analyst, New York
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Capital Markets
Life Sciences
Healthcare
Compensation and Benefits
Cyber/Data/Privacy
Tax
Life Sciences and Healthcare Regulatory
CFIUS
Labor and Employment
Antitrust and Competition

Eagle Pharmaceuticals’ Cooperation Agreement With Nantahala Capital Management

Eagle Pharmaceuticals’ Cooperation Agreement With Nantahala Capital Management

August 28, 2025

Cooley advised Eagle Pharmaceuticals, a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise, on its cooperation agreement with Nantahala Capital Management, a holder of approximately 38% of Eagle’s outstanding shares.

Read more

Related contacts

Bill Roegge
Partner, New York
Sarah Sellers
Partner, New York
Marc Recht
Partner, Boston
Pat O'Connell
Associate, New York
Asa Henin
Partner, San Diego
Paul Alexander
Associate, Washington, DC
Nathan Baum
Special Counsel, New York
Luke Cadigan
Partner in Charge – Boston, Boston
Tijana Brien
Partner, Palo Alto
Ariane A. Andrade
Partner, Chicago

Related Practices & Industries

Activism Defense
Mergers and Acquisitions
Capital Markets

Cooley Advises Special Committee of Checkpoint on Acquisition by Sun Pharma

Cooley Advises Special Committee of Checkpoint on Acquisition by Sun Pharma

March 9, 2025

Cooley advised the special committee of Checkpoint Therapeutics’ (Nasdaq: CKPT) board of directors in connection with Checkpoint’s definitive agreement to be acquired by Sun Pharmaceutical Industries (NSE: SUNPHARMA) for up to $416 million in cash and contingent value rights.

Read more

Related contacts

Bill Roegge
Partner, New York
Kevin Cooper
Partner, New York
Marc Recht
Partner, Boston
Wesley Dietrich
Associate, Washington, DC
Kathryn Benvenuti
Associate, New York
Michael Bergmann
Partner, Washington, DC
Eileen Marshall
Partner, Washington, DC
Alan W. Tamarelli
Partner, New York
Julia R. Brinton
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Stella Sarma
Partner, Brussels
Natasha Leskovsek
Of Counsel, Washington, DC
Karun Ahuja
Special Counsel, Chicago
Matthew Choy
Associate, New York
Jameson Davis
Associate, Boston
Kyle Hess
Associate, New York
Allison Kutner
Associate, New York
Breanna Qin
Associate, Palo Alto
Arda Can Tekin
Associate, London
Ryan Vann
Partner, Chicago

Related Practices & Industries

Mergers and Acquisitions
Life Sciences
Healthcare
Capital Markets
Cyber/Data/Privacy
Antitrust and Competition
Compensation and Benefits
Life Sciences Corporate Partnering and Licensing
Tax
Labor and Employment
Life Sciences and Healthcare Regulatory
CFIUS

Enavate Sciences Co-Leads Normunity’s $75 Million Series B

Enavate Sciences Co-Leads Normunity’s $75 Million Series B

January 13, 2025

Cooley advised Enavate Sciences, a top investment firm, as the co-lead investor in the $75 million Series B financing round of Normunity, a biotechnology company creating novel anticancer therapies. Lawyers Marc Recht, Brandon Fenn and Barry Kuang led the Cooley team advising Enavate Sciences.

Related contacts

Marc Recht
Partner, Boston
Brandon W. Fenn
Partner, New York
Barry Kuang
Associate, Boston
Liz Gold
Associate, New York
Stephanie Gentile
Partner, New York

Related Practices & Industries

Emerging Companies
Venture Capital
Life Sciences
Tax

Enavate Sciences Invests in Aviceda Therapeutics $207.5 Million Series C

Enavate Sciences Invests in Aviceda Therapeutics $207.5 Million Series C

January 7, 2025

Cooley advised Enavate Sciences, a top investment firm, on its participation in the $207.5 million Series C financing round of Aviceda Therapeutics, a clinical-stage biotech company focused on developing next-generation immunomodulators. Lawyers Marc Recht, Brandon Fenn and Barry Kuang led the Cooley team advising Enavate Sciences.

Related contacts

Marc Recht
Partner, Boston
Brandon W. Fenn
Partner, New York
Barry Kuang
Associate, Boston

Related Practices & Industries

Life Sciences
Venture Capital
Emerging Companies
View more

Admissions and credentials

Massachusetts

Rankings and accolades

Chambers USA: Life Sciences: Corporate/Commercial – Massachusetts (2025)

Chambers USA: Capital Markets – Massachusetts (2014 – 2025)

The Legal 500 US: Healthcare: Life Sciences (2013, 2016, 2020)

Who's Who Legal: Life Sciences (2017, 2018)

Super Lawyers: Rising Star (2007, 2010 – 2013)

Boston Business Journal: Biotech IPO (2015)


Excellent in all categories. Marc Recht is 'very technically skilled in corporate matters and plays a strong quarterback role.'

The Legal 500 US